Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hajar Estiri

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell Journal|August 4, 2019
Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene TherapyAli Fallah, Hajar Estiri, Elizabeth Parrish, et al.
Iranian Journal of Cancer Prevention|January 29, 2015
Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor modelAzra Kenarkoohi, Masoud Soleimani, Taravat Bamdad, et al.
The FEBS Journal|August 23, 2025
Development of a highly active engineered PETase enzyme for polyester degradationShapla Bhattacharya, Rossella Castagna, Hajar Estiri, et al.
Cell Journal|January 9, 2018
Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton's Jelly Stem CellsHajar Estiri, Ali Fallah, Masoud Soleimani, et al.
Cell Journal|August 25, 2017
Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice ModelAhmad Hosseini, Hajar Estiri, Haleh Akhavan Niaki, et al.
Scientific Reports|October 31, 2023
Tailoring FPOX enzymes for enhanced stability and expanded substrate recognitionHajar Estiri, Shapla Bhattacharya, Jhon Alexander Rodriguez Buitrago, et al.
Cell Journal|March 11, 2014
Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune DiseasesShohreh Hajizadeh-Sikaroodi, Ahmad Hosseini, Ali Fallah, et al.
Molecular Medicine Reports|April 10, 2014
Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-EpacHossein Mostafavi, Mojtaba Khaksarian, Mohammad Taghi Joghataei, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell Journal|August 4, 2019
Biosimilar Gene Therapy: Investigational Assessment of Secukinumab Gene TherapyAli Fallah, Hajar Estiri, Elizabeth Parrish, et al.
Iranian Journal of Cancer Prevention|January 29, 2015
Efficient lentiviral transduction of adipose tissue-derived mouse mesenchymal stem cells and assessment of their penetration in female mice cervical tumor modelAzra Kenarkoohi, Masoud Soleimani, Taravat Bamdad, et al.
The FEBS Journal|August 23, 2025
Development of a highly active engineered PETase enzyme for polyester degradationShapla Bhattacharya, Rossella Castagna, Hajar Estiri, et al.
Cell Journal|January 9, 2018
Stable Knockdown of Adenosine Kinase by Lentiviral Anti-ADK miR-shRNAs in Wharton's Jelly Stem CellsHajar Estiri, Ali Fallah, Masoud Soleimani, et al.
Cell Journal|August 25, 2017
Multiple Sclerosis Gene Therapy with Recombinant Viral Vectors: Overexpression of IL-4, Leukemia Inhibitory Factor, and IL-10 in Wharton's Jelly Stem Cells Used in EAE Mice ModelAhmad Hosseini, Hajar Estiri, Haleh Akhavan Niaki, et al.
Scientific Reports|October 31, 2023
Tailoring FPOX enzymes for enhanced stability and expanded substrate recognitionHajar Estiri, Shapla Bhattacharya, Jhon Alexander Rodriguez Buitrago, et al.
Cell Journal|March 11, 2014
Lentiviral Mediating Genetic Engineered Mesenchymal Stem Cells for Releasing IL-27 as a Gene Therapy Approach for Autoimmune DiseasesShohreh Hajizadeh-Sikaroodi, Ahmad Hosseini, Ali Fallah, et al.
Molecular Medicine Reports|April 10, 2014
Selective β2 adrenergic agonist increases Cx43 and miR-451 expression via cAMP-EpacHossein Mostafavi, Mojtaba Khaksarian, Mohammad Taghi Joghataei, et al.
Pageof 1